Overview

Study to Assess the Effect of Food on a Single Dose of Acoramidis in Healthy Adult Participants

Status:
Completed
Trial end date:
2021-08-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of a high-fat, high-caloric meal on the pharmacokinetics (PK) of acoramidis in healthy adult participants following an oral single dose administration of acoramidis. Blood sampling for PK assessment will include measures for acoramidis and its metabolite, acoramidis acyl glucuronide (acoramidis-AG).
Phase:
Phase 1
Details
Lead Sponsor:
Alexion Pharmaceuticals
Collaborator:
Celerion